EP2968155
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS
:
EP einkaleyfi: Þýðing ekki lögð inn:
12.3.2014:
3.3.2021:
14726410.5
:
11.3.2034
:
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS
12.3.2014
3.3.2021
:
Pfizer Inc.:
235 East 42nd Street, New York, NY 10017, US
:
HERBIG, Scott Max:
East Lyme, Connecticut 06333, US
:
KRISHNASWAMI, Sriram:
East Lyme, Connecticut 06333, US
:
KUSHNER IV, Joseph:
Bradford, Rhode Island 02808, US
:
LAMBA, Manisha:
Waterford, Connecticut 06385, US
:
STOCK, Thomas C.:
Chester Springs, Pennsylvania 19425, US
:
201361802479 P:
16.3.2013:
US
:
201361864059 P:
9.8.2013:
US
:
201461934428 P:
31.1.2014:
US
:
IB2014059689:
12.3.2014
:
A61K 9/28, A61K 9/48, A61K 31/519, A61P 1/04, A61P 17/06, A61P 19/02, A61P 37/06